This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hutchinson Technology's CEO Discusses F2Q 2011 Results - Earnings Call Transcript

Hutchinson Technology Incorporated ( HTCH)

F2Q 2011 Earnings Conference Call

April 26, 2011 5:00 PM EST

Executives

Chuck Ives – Treasurer and Director of IR

Wayne Fortun – CEO

Rick Penn – President, Disk Drive Components Division

Dave Radloff – CFO

Analysts

Sherri Scribner – Deutsche Bank

Eric Reubel – MTR Securities

Tom Lewis – High Road Value Research

Mark Miller – Noble Financial Capital Markets

David Epstein – CRT

Jeremy Skrezyna [ph] – Andalusia Capital Partners

Presentation

Operator

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to the Hutchinson Technology second quarter results conference call.

At this time, all participants are in a listen-only mode. And following the presentation, instructions will be given for the question-and-answer session. (Operator Instructions).

And as a reminder, this conference is being recorded today, April 26 th, 2011.

I would now like to turn the conference over to Chuck Ives. Please go ahead.

Chuck Ives

Good afternoon, everyone. Welcome to our second quarter results conference call. On the call with me today are Wayne Fortun, our Chief Executive Officer; Rick Penn, President of our Disk Drive Components Division; and Dave Radloff, our Chief Financial Officer.

Wayne will provide an overview of the business as well as a brief update on our BioMeasurement Division; Rick will provide an update on our Disk Drive Components Division; and Dave will speak to our financial results and guidance.

As a reminder we will be providing forward-looking information on-demand for and shipments of disk drives and the company’s products, market position, product mix, pricing, production capabilities and capacity, capacity utilization, assembly operations in Thailand, capital spending, product costs, manufacturing consolidation and restructuring, operating expenses, our BioMeasurement Division’s revenue and expenses, clinical evidence, product commercialization and adoption, and the company’s cost structure, operating performance and financial results.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,640.74 -89.37 -0.50%
S&P 500 2,062.60 -14.18 -0.68%
NASDAQ 4,973.4950 -35.7190 -0.71%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs